Gemini bioproducts:1110293 [17-000811]
Ended Awarded Last action
- Contract number
- HHSN26400003
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $20,636
Award facts
- Contract value 100% obligated
- $20,636.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Broderick, CA 95605, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$251 | |
| Original award | $20,887 |
About this award
Gemini Bioproducts LLC, a West Sacramento, California-based supplier of cell culture products and scientific reagents, received a Total Small Business set-aside contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. This Blanket Purchase Agreement (BPA) call, issued on November 28, 2016, carried a ceiling value of $20,636.26 under firm fixed-price terms and was scheduled for completion by March 18, 2022. The award reflects NIAMS's procurement of specialized biological products essential to the agency's research mission, leveraging Gemini Bioproducts' established expertise in supplying high-quality cell culture media, sera, and related reagents to federal biomedical research institutions.
This contract award represents a component of a broader procurement relationship, as Gemini Bioproducts maintains significant IDIQ agreements with federal agencies, including a $100 million Blanket Purchase Agreement for cell culture products and biological supplies. The company's selection under the small business set-aside designation underscores its qualification as a qualified supplier within the federal research ecosystem, where it has demonstrated consistent capability in delivering specialized materials to support the NIH's intramural and extramural research initiatives focused on musculoskeletal disease, arthritis, and dermatological conditions.
Quick answers
Who was awarded contract HHSN26400003?
HHSN26400003 was awarded to Gemini Bioproducts LLC by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on November 28, 2016.
How much is contract HHSN26400003 worth?
The government has obligated $20,636 on HHSN26400003.
Is contract HHSN26400003 an order under another contract?
Yes. HHSN26400003 is a BPA call under HHSN263201500189B, a blanket purchase agreement.
Was contract HHSN26400003 competed?
The extent of competition for HHSN26400003 was competed under sap. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award